- Home
- CLST vs FBRX Comparison
CLST vs FBRX Comparison
Compare CLST & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- FBRX
- Stock Information
- Founded
- CLST 1922
- FBRX N/A
- Country
- CLST United States
- FBRX United States
- Employees
- CLST N/A
- FBRX N/A
- Industry
- CLST
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- CLST
- FBRX Health Care
- Exchange
- CLST Nasdaq
- FBRX Nasdaq
- Market Cap
- CLST 48.8M
- FBRX 44.8M
- IPO Year
- CLST N/A
- FBRX N/A
- Fundamental
- Price
- CLST $11.85
- FBRX $9.13
- Analyst Decision
- CLST
- FBRX Strong Buy
- Analyst Count
- CLST 0
- FBRX 3
- Target Price
- CLST N/A
- FBRX $80.50
- AVG Volume (30 Days)
- CLST 5.1K
- FBRX 71.6K
- Earning Date
- CLST 04-24-2025
- FBRX 05-15-2025
- Dividend Yield
- CLST N/A
- FBRX N/A
- EPS Growth
- CLST N/A
- FBRX N/A
- EPS
- CLST 0.57
- FBRX N/A
- Revenue
- CLST $11,257,000.00
- FBRX N/A
- Revenue This Year
- CLST N/A
- FBRX N/A
- Revenue Next Year
- CLST N/A
- FBRX N/A
- P/E Ratio
- CLST $21.12
- FBRX N/A
- Revenue Growth
- CLST 200.91
- FBRX N/A
- 52 Week Low
- CLST $10.67
- FBRX $4.11
- 52 Week High
- CLST $12.40
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- CLST 62.86
- FBRX 53.25
- Support Level
- CLST $11.62
- FBRX $8.25
- Resistance Level
- CLST $12.00
- FBRX $13.84
- Average True Range (ATR)
- CLST 0.11
- FBRX 1.31
- MACD
- CLST 0.02
- FBRX 0.11
- Stochastic Oscillator
- CLST 100.00
- FBRX 26.48
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).